AGN Share Price Performance
AU$0
-0.63 (-100.00%)
Price AU$0
Share Pricen/a
We're Hopeful That Argenica Therapeutics (ASX:AGN) Will Use Its Cash Wisely
Sep 03
Argenica Therapeutics Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
AGN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Argenica Therapeutics Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.056
- 100.00%
- -223.11%
- 0%
About AGN
- Founded
- 2019
- Employees
- n/a
- CEO
- WebsiteView website
Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
